Related Experiment Video

Updated: Mar 5, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

43.3K

Basic Concepts in Metastatic Cardiac Disease

Panagiotis J Vlachostergios1, Danai D Daliani1, Christos N Papandreou1

  • 1Department of Medical Oncology, University Hospital of Larissa, University of Thessaly School of Medicine, Biopolis 41110, Larissa, Greece.

Cardiology Research
|March 29, 2017
PubMed

Insights

Metastatic cancer involving the heart is rare and often asymptomatic, making diagnosis challenging. This review covers the incidence, location, presentation, diagnosis, and treatment of cardiac tumors in cancer patients.

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Cardiac metastases are uncommon in clinical practice.
  • Symptoms of heart involvement by cancer are often absent or non-specific.
  • Metastatic heart tumors can be misdiagnosed or attributed to other conditions.

Purpose of the Study:

  • To review the incidence of cardiac metastases.
  • To discuss the clinical presentation and diagnosis of metastatic heart tumors.
  • To outline current treatment strategies for cardiac tumors in cancer patients.

Main Methods:

  • Literature review of studies on metastatic cardiac tumors.
  • Analysis of reported cases regarding incidence and location.
  • Synthesis of diagnostic and therapeutic approaches.

Main Results:

  • Cardiac involvement by cancer is a rare diagnosis.
  • Intracardiac location and clinical presentation vary widely.
  • Diagnosis often relies on advanced imaging and biopsy.
  • Treatment is typically palliative.

Conclusions:

  • Early recognition of cardiac metastases is crucial despite rarity.
  • Multidisciplinary approach is essential for optimal management.
  • Further research is needed to improve outcomes for patients with metastatic heart tumors.

Keywords:
CancerHeart metastasis

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

7.0K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
718
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
371